Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats
- 22 November 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 527 (1-3) , 129-140
- https://doi.org/10.1016/j.ejphar.2005.10.018
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injuryCardiovascular Research, 2004
- Lovastatin Enhances Ecto-5′-Nucleotidase Activity and Cell Surface Expression in Endothelial CellsCirculation Research, 2002
- Protective effects of poly (adp-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated heartsPharmacological Research, 2002
- Rho-dependent Agonist-induced Spatio-temporal Change in Myosin Phosphorylation in Smooth Muscle CellsJournal of Biological Chemistry, 2002
- Antiischemic Properties of Fasudil in Experimental Models of Vasospastic AnginaThe Japanese Journal of Pharmacology, 2001
- Antianginal effects of hydroxyfasudil, a Rho‐kinase inhibitor, in a canine model of effort anginaBritish Journal of Pharmacology, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Inhibition of Neutrophil Migration by a Protein Kinase Inhibitor for the Treatment of Ischemic Brain InfarctionThe Japanese Journal of Pharmacology, 1999
- The effects of the Rho‐kinase inhibitor Y‐27632 on arachidonic acid‐, GTPγS‐, and phorbol ester‐induced Ca2+‐sensitization of smooth muscleFEBS Letters, 1998
- Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heartHeart and Vessels, 1997